Link to this page
Ontology of Cardiovascular Drug Adverse Events
Last uploaded:
December 29, 2016
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000008140
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000008140
|
|---|---|
| Preferred Name | Cardanolides [Chemical/Ingredient] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Cardanolides [Chemical/Ingredient]
|
|---|---|
| prefLabel |
Cardanolides [Chemical/Ingredient]
|
| NUI |
N0000008140
|
| code |
C26644
|
| prefixIRI |
NDF-RT:N0000008140
|
| RxNorm_CUI |
2077
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0003447
|
| MeSH_DUI |
D002297
|
| type | |
| MeSH_Name |
Cardanolides
|
| UMLS_CUI |
C0007142
|
| Display_Name |
Cardanolides
|
| MeSH_Definition |
The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |